{"id":16983,"date":"2018-12-19T15:18:48","date_gmt":"2018-12-19T14:18:48","guid":{"rendered":"http:\/\/mabdesign.fr\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/"},"modified":"2018-12-19T15:18:48","modified_gmt":"2018-12-19T14:18:48","slug":"polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/","title":{"rendered":"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production"},"content":{"rendered":"

Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production<\/strong><\/p>\n

Strasbourg, December 13th 2018 –\u00a0Polyplus-transfection\u00ae SA, a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction and therapeutics, today announces the launch of PEIpro\u00ae-GMP, a transfection reagent designed for the clinical and commercial lentivirus and adeno-associated virus (AAV) production of cell & gene therapies.<\/p>\n

Polyplus-transfection has released PEIpro-GMP to provide a solution for the cell and gene therapy industry faced with tightening regulations. The increase in regulatory requirements include the use of reagents as raw material in the production of viruses for clinical trials, specifically mandating higher levels of quality compliance at earlier stages of clinical development.
\nAs a result, industrial viral vector production for cell & gene therapy has to increase in quality, with the essential use of cGMP compliant raw materials such as plasmids. Polyplus-transfection\u2019s latest product, PEIpro-GMP, has been designed as the highest quality grade transfection reagent available on the market that is compliant with all cGMP viral vector manufacturing requirements.<\/p>\n

Pour en savoir plus<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32],"tags":[],"class_list":["post-16983","post","type-post","status-publish","format-standard","hentry","category-news","category-our-members"],"yoast_head":"\nPolyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production - MabDesign<\/title>\n<meta name=\"description\" content=\"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-19T14:18:48+00:00\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production\",\"datePublished\":\"2018-12-19T14:18:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/\"},\"wordCount\":194,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/\",\"name\":\"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"datePublished\":\"2018-12-19T14:18:48+00:00\",\"description\":\"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production - MabDesign","description":"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/","og_locale":"en_US","og_type":"article","og_title":"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production - MabDesign","og_description":"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production","og_url":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/","og_site_name":"MabDesign","article_published_time":"2018-12-19T14:18:48+00:00","author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production","datePublished":"2018-12-19T14:18:48+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/"},"wordCount":194,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/","url":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/","name":"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"datePublished":"2018-12-19T14:18:48+00:00","description":"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/polyplus-transfection-further-expands-transfection-reagent-portfolio-for-cell-and-gene-therapy-gmp-production\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Polyplus-transfection\u00ae further expands transfection reagent portfolio for Cell and Gene therapy GMP production"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=16983"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16983\/revisions"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=16983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=16983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=16983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}